Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G

Introduction: Immunotherapy is being used for the past five years either as first line or second line treatment with great results. Chemotherapy and radiotherapy have been also used as combination to immunotherapy to further enhance this type of treatment. Intratumoral treatment has been previously...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer
Auteurs principaux: Zarogoulidis, Paul, Hohenforst-Schmidt, Wolfgang, Huang, Haidong, Zhou, Jun, Wang, Qin, Wang, Xiangqi, Xia, Ying, Ding, Yinfeng, Bai, Chong, Kosmidis, Christoforos, Sapalidis, Konstantinos, Sardeli, Chrysanthi, Tsakiridis, Kosmas, Zaric, Bojan, Kovacevic, Tomi, Stojsic, Vladimir, Sarcev, Tatjana, Bursac, Daliborka, Kukic, Biljana, Baka, Sofia, Athanasiou, Evagelia, Hatzibougias, Dimitrios, Michalopoulou-Manoloutsiou, Electra, Petanidis, Savvas, Drougas, Dimitris, Drevelegas, Konstantinos, Paliouras, Dimitris, Barbetakis, Nikolaos, Vagionas, Anastasios, Freitag, Lutz, Lallas, Aimilios, Boukovinas, Ioannis, Petridis, Dimitris, Ioannidis, Aris, Matthaios, Dimitris, Romanidis, Konstantinos, Karapantzou, Chrisanthi
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2021
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040712/
https://ncbi.nlm.nih.gov/pubmed/33854617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.55322
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires